
Novel мощный and селективный blocker of the calcineurin-NFAT interaction (KD=16nM), preventing acute lung injury, being a promising novel treatment for ARDS and other inflammatory diseases
Novel potent and selective blocker of the calcineurin-NFAT interaction (KD=16nM), preventing acute lung injury, being a promising novel treatment for ARDS and other inflammatory diseases
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.